Clinical Social Workers in Washington, IL Accepting Medicare

7 Clinical Social Workers found. Showing 1 - 7

Josey Renee Schouweiler, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 128 Washington Sq, Washington, IL 61571 Phone: 309-481-5177    Fax: 800-773-1682

Jacquelin Diane Ejka, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1003 N Cummings Ln, Washington, IL 61571 Phone: 309-444-1000    Fax: 309-444-7000

Lori Kyle, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 10 Saint Clare Ct, Washington, IL 61571 Phone: 309-866-4000

Mrs. Haily Nicole Lipps, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1008 Miller St, Washington, IL 61571 Phone: 309-215-2341

Mrs. Chelsea Patricia Tapp, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 120 Eastgate Dr, Washington, IL 61571 Phone: 309-423-3111

Jessica M Thompson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Dr, Suite E, Washington, IL 61571 Phone: 309-444-2800    Fax: 309-444-2866

Theresa A Wiese, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 310 Hillcrest Dr, Washington, IL 61571 Phone: 309-645-1318

News Archive

The SARS-CoV-2 virus and its vaccines pose unique challenges

Iranian researchers recently provided a review of the attempts made to develop safe SARS-CoV-2 vaccines. The researchers outlined potential challenges and concerns, including disease enhancement, virus mutation, and public acceptability. Their work is published in the journal Immunological Investigations.

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Health reform will create demand for primary care physicians, rural docs especially squeezed

The Associated Press: "Primary care physicians already are in short supply in parts of the country, and the landmark health overhaul that will bring them millions more newly insured patients in the next few years promises extra strain. ... Recently published reports predict a shortfall of roughly 40,000 primary care doctors over the next decade, a field losing out to the better pay, better hours and higher profile of many other specialties.

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.

Novel avenues to treat heart attack

Novel avenues to treat a heart attack: in patients, who have a blood pressure cuff several times briefly inflated before they undergo coronary artery surgery with cardiopulmonary bypass, the heart is protected from damage.

Read more Medical News

› Verified 3 days ago